Prevention of anaphylaxis to contrast medium.
D000790:Angiocardiography / Q000009:adverse effects; D000792:Angiography / Q000009:adverse effects*; D003973:Diatrizoate / Q000031:analogs & derivatives*; D003974:Diatrizoate Meglumine / Q000008:administration & dosage / Q000009:adverse effects*; D004155:Diphenhydramine / Q000008:administration & dosage / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000188:drug therapy / Q000517:prevention & control*; D004837:Epinephrine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged
D003973:Diatrizoate; D003974:Diatrizoate Meglumine; D004155:Diphenhydramine; D008775:Methylprednisolone; D004837:Epinephrine